Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Probiotics on Biomarkers and Symptom Severity in Irritable Bowel Syndrome

NCT07584278 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.

NCT NCT07584278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07584278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Probiotics on Biomarkers and Symptom Severity in Irritable Bowel Syndrome
Lead sponsor
Sahlgrenska University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 28, 2026
Completion date
May 31, 2031
Enrollment
252 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome (ibs)